Commercial Loans Secured Transactions Banking Law Banking Regulation Loan Workouts Trade Finance Asset Based Finance Securitization Bankruptcy Corporate Law Real Estate Partnership Law Limited Liability Company Law
Dr. Morrow graduated from the Harvard Medical School in 1994. He works in Boston, MA and specializes in Cardiovascular Disease. Dr. Morrow is affiliated with Brigham & Womens Hospital.
Dr. Morrow graduated from the Saint Louis University School of Medicine in 1992. He works in Santa Clarita, CA and specializes in Family Medicine. Dr. Morrow is affiliated with Henry Mayo Newhall Hospital and Providence Holy Cross Medical Center.
Bassett Physician GroupBassett Medical Center General Surgery 1 Atwell Rd, Cooperstown, NY 13326 6075473373 (phone), 6075476553 (fax)
Education:
Medical School University of Vermont COM Graduated: 2011
Languages:
English
Description:
Dr. Morrow graduated from the University of Vermont COM in 2011. He works in Cooperstown, NY and specializes in General Surgery. Dr. Morrow is affiliated with Bassett Medical Center.
Morrow Institute 69780 Stellar Dr, Rancho Mirage, CA 92270 7602022770 (phone), 7602024676 (fax)
Education:
Medical School University of Tennessee College of Medicine at Memphis Graduated: 1970
Languages:
English Spanish
Description:
Dr. Morrow graduated from the University of Tennessee College of Medicine at Memphis in 1970. He works in Rancho Mirage, CA and specializes in Cosmetic Surgery and Dermatology. Dr. Morrow is affiliated with Eisenhower Medical Center.
Arcadia Elementary School Tuscaloosa AL 1972-1978, Tuscaloosa Junior High School Tuscaloosa AL 1978-1979, Eastwood Middle School Tuscaloosa AL 1979-1980
Dr. David Morrow of Brigham and Women's Hospital in Boston told the gathering at the American College of Cardiology that 11.2% of the patients taking vorapaxar experienced a cardiovascular event, such as heart attack, stroke or death, compared to 12.4% of the patients in the control arm. Here's the
died from heart-related causes versus more than 10 percent of those not given the drug. Moderate or severe bleeding occurred in about 4 percent of those on vorapaxar versus just more than 2 percent of the others, said the studys leader, Dr. David Morrow of Brigham and Womens Hospital in Boston.
Date: Mar 25, 2012
Category: Health
Source: Google
WSJ UPDATE: Merck Anticlotting Drug Shows Benefit And Risk -Study
"There is a clear signal of efficacy," said David Morrow, a researcher atHarvard-affiliated Brigham and Women's Hospital, Boston and lead author of thestudy. He added that the increased bleeding risk was "unacceptably high inpatients with a previous stroke." Weighing under about 130 pounds was a
had died from heart-related causes versus more than 10 percent of those not given the drug. Moderate or severe bleeding occurred in about 4 percent of those on vorapaxar versus just more than 2 percent of the others, said the study's leader, Dr. David Morrow of Brigham and Women's Hospital in Boston.
a stroke or had died from heart-related causes versus more than 10 percent of those not given the drug. Moderate or severe bleeding occurred in about 4% of those on vorapaxar versus just more than 2% of the others, said the study's leader, Dr. David Morrow of Brigham and Women's Hospital in Boston.
Date: Mar 24, 2012
Category: Health
Source: Google
Merck blood clot drug in limbo after mixed results
"This is the first time we've seen the addition of any new type of anti-platelet drug provide additional long-term protection among stable patients with a history of heart attack," said Dr. David Morrow, a cardiologist from Brigham & Women's Hospital in Boston who led the trial.
"Of the groups we studied, the benefit was compelling to us only in patients with a prior heart attack," said a statement by lead investigator David Morrow, director of the Samuel A. Levine Cardiac Unit at Brigham & Women's Hospital.
The rate of cardiovascular death, MI, or stroke was 9.3% with vorapaxar and 10.5% with placebo (HR 0.87, 95% CI 0.80 to 0.94), according to David Morrow, MD, MPH, of Brigham and Women's Hospital in Boston.